Envision Healthcare
EVHC
Delayed Nyse - 04/21 10:02:01 pm
54.54USD
-1.48%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 69610 526
Operating income (EBITDA)6311 381
Operating profit (EBIT)5681 156
Pre-Tax Profit (EBT)--
Net income-27,7384
EPS ( $ )-0,473,12
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5074 448
Finance--
Operating income (EBITDA)6311 381
Leverage
(Debt/EBITDA)
8,73x3,22x
Capital Expenditure99,5184
Book Value Per Share (BVPS)57,3 $61,8 $
Cash Flow per Share6,66 $8,07 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 6 410 M$ -
Entreprise Value (EV) 10 857 M$ 11 046 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 17,5x 14,4x
Capitalization / Revenue 0,61x 0,56x
EV / Revenue 1,03x 0,97x
EV / EBITDA 7,86x 7,11x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,88x 0,84x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 11,0% 11,5%
operating Leverage (Delta EBIT / Delta Sales) 0,56x 1,62x
Net Margin (Net Profit / Revenue) 3,65% 4,10%
ROA (Net Profit / Asset) 3,00% 3,40%
ROE (Net Profit / Equities) 7,11% 7,89%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,74% 1,69%
Cash Flow / Sales 9,01% 9,23%
Capital Intensity (Assets / Sales) 1,22x 1,21x
Financial Leverage (Net Debt / EBITDA) 3,22x 2,98x
Price Earning Ratio
BNA & Dividende